Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Merus Labs International Inc (NASDAQ:MSLI)

0.7999
Delayed Data
As of 2:47pm ET
 +0.0299 / +3.88%
Today’s Change
0.70
Today|||52-Week Range
1.90
-8.06%
Year-to-Date
What Makes Merus Labs (MSLI) a Strong Sell?
Jan 09 / Zacks.com - Paid Partner Content
 

Today’s Trading

Previous close0.77
Today’s open0.78
Day’s range0.76 - 0.80
Volume9,400
Average volume (3 months)24,830
Market cap$90.1M
Dividend yield--
Data as of 2:47pm ET, 01/20/2017

Growth & Valuation

Earnings growth (last year)-3,133.33%
Earnings growth (this year)+47.48%
Earnings growth (next 5 years)+1.14%
Revenue growth (last year)+72.51%
P/E ratio--
Price/Sales1.62
Price/Book0.60

Competitors

 Today’s
change
Today’s
% change
CRMECardiome Pharma Corp+0.07+2.47%
TTNPTitan Pharmaceutical...-0.10-2.35%
VCELVericel Corp-0.05-1.82%
CATBCatabasis Pharmaceut...-0.47-9.46%
Data as of 4:00pm ET, 01/20/2017

Financials

Next reporting dateFebruary 15, 2017
EPS forecast (this quarter)-$0.02
Annual revenue (last year)$68.7M
Annual profit (last year)-$7.1M
Net profit margin-10.39%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chief Executive Officer &
Director
Barry Fishman
Chief Financial Officer
Michael Bumby
Corporate headquarters
Toronto, Ontario

Forecasts


Search for Jobs